SCHEMBL1092973

SCHEMBL1092973

N=CCCCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4251139 0.76
SCHEMBL250773 0.72
SCHEMBL11675348 0.69
SCHEMBL11675345 0.69
SCHEMBL24448699 0.64
SCHEMBL936225 0.64
SCHEMBL2782746 0.64
SCHEMBL22485671 0.64
SCHEMBL4201088 0.64
SCHEMBL4197116 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0711178-B1 BLOOD POOL IMAGING COMPOSITION AND METHOD OF ITS USE GEN HOSPITAL CORP (US) 2003-05-21 EP claimed
EP-1196200-A2 A RADIOLABELED MAMMALIAN TACHYKININ PEPTIDE ANALOGUE Ortiz Aruma, Pedro (ES) 2002-04-17 EP claimed
WO-2001002021-A2 A RADIOLABELED MAMMALIAN TACHYKININ PEPTIDE ANALOGUE ORTIZ ARMUA PEDRO (ES) 2001-01-11 WO claimed
EP-0711178-A4 BLOOD POOL IMAGING COMPOSITION AND METHOD OF ITS USE GEN HOSPITAL CORP (US) 1999-12-08 EP claimed
US-5605672-A Blood pool imaging composition and method of its use THE GENERAL HOSPITAL CORPORATION (US) 1997-02-25 US claimed
EP-0711178-A1 BLOOD POOL IMAGING COMPOSITION AND METHOD OF ITS USE THE GENERAL HOSPITAL CORPORATION (US) 1996-05-15 EP claimed
WO-1994028940-A1 BLOOD POOL IMAGING COMPOSITION AND METHOD OF ITS USE THE GENERAL HOSPITAL CORPORATION (US) 1994-12-22 WO claimed
CN-117715933-A anti-VISTA constructs and uses thereof 当康生物技术有限责任公司 2024-03-15 CN disclosed
WO-2023239675-A1 STING AGONIST COMPOUNDS SUTRO BIOPHARMA, INC. (US) 2023-12-14 WO disclosed
EP-2087912-B1 SIRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE UNIV TOKYO (JP) 2017-05-10 EP disclosed
EP-2599834-B1 ELECTROSTATICALLY BONDED VESICLE UNIV TOKYO (JP) 2016-06-15 EP disclosed
US-9205157-B2 Anti ganglioside GD3 antibodies and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-12-08 US disclosed
US-9051437-B2 Electrostatically bonded vesicle THE UNIVERSITY OF TOKYO (JP) 2015-06-09 US disclosed
EP-2087912-A1 ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE The University of Tokyo (JP) 2009-08-12 EP disclosed
WO-2008101234-A2 ANTI GANGLIOSIDE GD3 ANTIBODIES AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2008-08-21 WO disclosed
EP-0711178-B1 BLOOD POOL IMAGING COMPOSITION AND METHOD OF ITS USE GEN HOSPITAL CORP (US) 2003-05-21 EP disclosed
EP-1196200-A2 A RADIOLABELED MAMMALIAN TACHYKININ PEPTIDE ANALOGUE Ortiz Aruma, Pedro (ES) 2002-04-17 EP disclosed
US-6241961-B1 ADMINISTERING TO BONE MARROW OF PATIENT A DOSE OF A MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT STABLY COUPLED TO A CADMIUM-66 RADIOISOTOPE; SIDE EFFECT REDUCTION BENES IVAN FRIEDRICH (CH) 2001-06-05 US disclosed
WO-2001002021-A2 A RADIOLABELED MAMMALIAN TACHYKININ PEPTIDE ANALOGUE ORTIZ ARMUA PEDRO (ES) 2001-01-11 WO disclosed
EP-0972528-A2 Radioimmunoconjugate for use in human therapy and its preparation Benes, Ivan Friedrich Dr. med. Dr. rer. nat. PhD. (CH) 2000-01-19 EP disclosed